Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial

Lale Erdem-Eraslan; Martin J. van den Bent; Youri Hoogstrate; Hina Naz-Khan; Andrew Stubbs; Peter van der Spek; René Bottcher; Ya Gao; Maurice de Wit; Walter Taal; Hendrika M. Oosterkamp; Annemiek Walenkamp; Laurens V. Beerepoot; Monique C.J. Hanse; Jan Buter; Aafke H. Honkoop; Bronno van der Holt; René M. Vernhout; P. A. E. S. Smitt; Johan M. Kros; Pim J. French

Cancer Research (2016) - Comment
pubmed: 26762204 doi: 10.1158/0008-5472.can-15-0776 issn: 1538-7445 issn: 0008-5472

Lale Erdem-Eraslan, Martin J. Van Den Bent, Youri Hoogstrate, Hina Naz-Khan, Andrew Stubbs, Peter Van Der Spek, René Bottcher, Ya Gao, Maurice De Wit, Walter Taal, Hendrika M. Oosterkamp, Annemiek Walenkamp, Laurens V. Beerepoot, Monique C.J. Hanse, Jan Buter, Aafke H. Honkoop, Bronno Van Der Holt, René M. Vernhout, P. A. E. S. Smitt, Johan M. Kros

Go to article
Go to preprint

American Association for Cancer Research (AACR)